News|Articles|September 23, 2024
Nitrosamines, Meeting Regulatory Requirements
Author(s)Phenomenex, Inc.
The necessity to analyse drug products for nitrosamines and NDSRIs (Nitrosamine Drug Substance Related Impurities) is well documented. In this document we provide an overview of 7 of our most recent applications in this area, together with links to the relevant technical notes.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Native Capillary Electrophoresis–Mass Spectrometry Enables Quantitative Profiling of Endogenous Protein Complexes
2
Event Preview: 2nd Green Analytical Chemistry Workshop
3
Validated LC–MS/MS Method for Therapeutic Drug Monitoring of Thiopurine Metabolites in Red Blood Cells
4
Modeling and Chemical Characterization of Grape Stem Extracts for Antioxidant Product Design
5